Bank of Montreal
LJPC

Bank of Montreal’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Bank of Montreal’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100
Closed -$3K – 4515
2017
Q2 		$3K Buy
+100
New +$2.87K ﹤0.01% 4007

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Montreal's LJPC Position: Q2 2021 in Review

Bank of Montreal sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2021, closing a stake of 432 shares — an estimated $2K sold.

Bank of Montreal first reported a position in LJPC in Q1 2014 and held it in 17 quarters. The position peaked at $379K in Q3 2017. 62 funds tracked by Wall St. Rank hold LJPC as of Q2 2021.

  • Bank of Montreal reported no remaining La Jolla Pharmaceutical Company position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 432 La Jolla Pharmaceutical Company shares in Q2 2021, an estimated $2K.
  • Bank of Montreal first reported a position in La Jolla Pharmaceutical Company in Q1 2014 and held it in 17 quarters.
  • Bank of Montreal's La Jolla Pharmaceutical Company position peaked at $379K in Q3 2017.
  • 62 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.